Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Downgrades
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Roth Capital downgraded the previous rating for Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) from Buy to Sell. Arcturus Therapeutics earned $0.92 in the third quarter, compared to $0.56 in the year-ago quarter. The stock has a 52-week-high of $129.71 and a 52-week-low of $8.51. At the end of the last trading period, Arcturus Therapeutics closed at $118.46.
- According to BMO Capital, the prior rating for FuboTV Inc (NYSE:FUBO) was changed from Outperform to Market Perform. FuboTV earned $1.65 in the third quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $62.29 and a 52-week-low of $8.12. At the end of the last trading period, FuboTV closed at $62.19.
- For PaySign Inc (NASDAQ:PAYS), Canaccord Genuity downgraded the previous rating of Buy to Hold. In the third quarter, PaySign showed an EPS of $0.14, compared to $0.06 from the year-ago quarter. At the moment, the stock has a 52-week-high of $10.98 and a 52-week-low of $3.63. PaySign closed at $4.91 at the end of the last trading period.
- BMO Capital downgraded the previous rating for IAC/InterActiveCorp (NASDAQ:IAC) from Outperform to Market Perform. IAC/InterActiveCorp earned $0.11 in the third quarter, compared to $1.35 in the year-ago quarter. The current stock performance of IAC/InterActiveCorp shows a 52-week-high of $324.74 and a 52-week-low of $100.22. Moreover, at the end of the last trading period, the closing price was at $183.73.
Initiations
- CMB International initiated coverage on iHuman Inc (NYSE:IH) with a Buy rating. The price target for iHuman is set to $26.08. In the third quarter, iHuman earned $0.03. At the moment, the stock has a 52-week-high of $31.58 and a 52-week-low of $16.07. iHuman closed at $21.10 at the end of the last trading period.
- With an Outperform rating, JMP Securities initiated coverage on Evelo Biosciences Inc (NASDAQ:EVLO). The price target seems to have been set at $27.00 for Evelo Biosciences. Evelo Biosciences earned $0.45 in the third quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $11.84 and a 52-week-low of $3.01. At the end of the last trading period, Evelo Biosciences closed at $11.20.
- Piper Sandler initiated coverage on Cogent Biosciences Inc (NASDAQ:COGT) with an Overweight rating. The price target for Cogent Biosciences is set to $22.00. In the third quarter, Cogent Biosciences showed an EPS of $0.31, compared to $1.56 from the year-ago quarter. The stock has a 52-week-high of $14.44 and a 52-week-low of $8.40. At the end of the last trading period, Cogent Biosciences closed at $12.20.
- Benchmark initiated coverage on CC Neuberger Principal Holdings I (NYSE:PCPL) with a Buy rating. The price target for CC Neuberger Principal is set to $15.00. The current stock performance of CC Neuberger Principal shows a 52-week-high of $11.29 and a 52-week-low of $9.95. Moreover, at the end of the last trading period, the closing price was at $10.80.
- With a Neutral rating, Baird initiated coverage on Square Inc (NYSE:SQ). The price target seems to have been set at $245.00 for Square. Square earned $0.34 in the third quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $243.38 and a 52-week-low of $32.33. Square closed at $241.57 at the end of the last trading period.
- With an Outperform rating, Baird initiated coverage on Qualcomm Inc (NASDAQ:QCOM). The price target seems to have been set at $200.00 for Qualcomm. In the fourth quarter, Qualcomm showed an EPS of $1.45, compared to $0.78 from the year-ago quarter. The stock has a 52-week-high of $161.07 and a 52-week-low of $58.00. At the end of the last trading period, Qualcomm closed at $146.34.
- JMP Securities initiated coverage on Seres Therapeutics Inc (NASDAQ:MCRB) with a Market Perform rating. Seres Therapeutics earned $0.36 in the third quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $38.50 and a 52-week-low of $2.52. Seres Therapeutics closed at $24.78 at the end of the last trading period.
- Santander initiated coverage on Linx SA (NYSE:LINX) with a Hold rating. The price target for Linx is set to $7.60. In the third quarter, Linx showed an EPS of $0.01, compared to $0.00 from the year-ago quarter. At the moment, the stock has a 52-week-high of $9.47 and a 52-week-low of $2.83. Linx closed at $7.24 at the end of the last trading period.
- With a Neutral rating, Baird initiated coverage on Luminar Technologies Inc (NASDAQ:LAZR). The price target seems to have been set at $30.00 for Luminar Technologies. At the moment, the stock has a 52-week-high of $47.80 and a 52-week-low of $19.10. Luminar Technologies closed at $37.37 at the end of the last trading period.
- With a Buy rating, Stifel initiated coverage on Lithium Americas Corp (NYSE:LAC). The price target seems to have been set at $13.25 for Lithium Americas. Lithium Americas earned $0.07 in the third quarter, compared to $0.06 in the year-ago quarter. The current stock performance of Lithium Americas shows a 52-week-high of $16.97 and a 52-week-low of $1.92. Moreover, at the end of the last trading period, the closing price was at $11.35.
- JMP Securities initiated coverage on Kaleido Biosciences Inc (NASDAQ:KLDO) with an Outperform rating. The price target for Kaleido Biosciences is set to $22.00. Kaleido Biosciences earned $0.65 in the third quarter, compared to $0.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.89 and a 52-week-low of $2.82. Kaleido Biosciences closed at $8.99 at the end of the last trading period.
- With a Buy rating, CMB International initiated coverage on iQIYI Inc (NASDAQ:IQ). The price target seems to have been set at $23.20 for iQIYI. For the third quarter, iQIYI had an EPS of $0.24, compared to year-ago quarter EPS of $0.70. At the moment, the stock has a 52-week-high of $28.03 and a 52-week-low of $14.51. iQIYI closed at $16.97 at the end of the last trading period.
- National Securities Corporation initiated coverage on Humanigen Inc (NASDAQ:HGEN) with a Buy rating. The price target for Humanigen is set to $35.00. The stock has a 52-week-high of $33.95 and a 52-week-low of $3.40. At the end of the last trading period, Humanigen closed at $20.79.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.